Wave 2 strains of atypical Vibrio cholerae El Tor caused the 2009-2011 cholera outbreak in Papua New Guinea.


Journal

Microbial genomics
ISSN: 2057-5858
Titre abrégé: Microb Genom
Pays: England
ID NLM: 101671820

Informations de publication

Date de publication:
03 2019
Historique:
pubmed: 28 2 2019
medline: 24 3 2020
entrez: 28 2 2019
Statut: ppublish

Résumé

Vibrio cholerae is the causative agent of cholera, a globally important human disease for at least 200 years. In 2009-2011, the first recorded cholera outbreak in Papua New Guinea (PNG) occurred. We conducted genetic and phenotypic characterization of 21 isolates of V. cholerae, with whole-genome sequencing conducted on 2 representative isolates. The PNG outbreak was caused by an atypical El Tor strain harbouring a tandem repeat of the CTX prophage on chromosome II. Whole-genome sequence data, prophage structural analysis and the absence of the SXT integrative conjugative element was indicative that the PNG isolates were most closely related to strains previously isolated in South-East and East Asia with affiliations to global wave 2 strains. This finding suggests that the cholera outbreak in PNG was caused by an exotic (non-endemic) strain of V. cholerae that originated in South-East Asia.

Identifiants

pubmed: 30810520
doi: 10.1099/mgen.0.000256
pmc: PMC6487313
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Bull World Health Organ. 2012 Mar 1;90(3):209-218A
pubmed: 22461716
N Engl J Med. 2011 Jan 6;364(1):33-42
pubmed: 21142692
PLoS One. 2008;3(12):e4053
pubmed: 19115014
Science. 2017 Nov 10;358(6364):785-789
pubmed: 29123067
J Antimicrob Chemother. 2012 Nov;67(11):2640-4
pubmed: 22782487
Western Pac Surveill Response J. 2012 Mar 27;3(1):3-5
pubmed: 23908900
Emerg Infect Dis. 2011 Jul;17(7):1161-8
pubmed: 21762567
J Clin Microbiol. 2009 May;47(5):1568-71
pubmed: 19297603
Nature. 2011 Aug 24;477(7365):462-5
pubmed: 21866102
Lancet. 2012 Jun 30;379(9835):2466-2476
pubmed: 22748592
PLoS Genet. 2015 Mar 13;11(3):e1005072
pubmed: 25768799
Lancet. 1993 Jun 26;341(8861):1661
pubmed: 8100020
Science. 2017 Nov 10;358(6364):789-793
pubmed: 29123068
Nucleic Acids Res. 2015 Feb 18;43(3):e15
pubmed: 25414349
J Clin Microbiol. 2002 Sep;40(9):3296-9
pubmed: 12202569
J Clin Microbiol. 2006 Nov;44(11):4211-3
pubmed: 16957040
J Med Microbiol. 2009 Jan;58(Pt 1):105-111
pubmed: 19074660
Western Pac Surveill Response J. 2012 May 23;3(2):30-2
pubmed: 23908909
Emerg Infect Dis. 2011 Nov;17(11):2063-5
pubmed: 22099099
BMC Infect Dis. 2014 Aug 20;14:449
pubmed: 25141942
Bioinformatics. 2006 Nov 1;22(21):2688-90
pubmed: 16928733
mBio. 2015 Apr 21;6(2):
pubmed: 25900650
Indian J Med Res. 2008 Dec;128(6):695-8
pubmed: 19246791

Auteurs

Andrew R Greenhill (AR)

2​School of Health and Life Sciences, Federation University Australia, Churchill, Australia.
1​Papua New Guinea Institute of Medical Research, Goroka, Papua New Guinea.

Ankur Mutreja (A)

3​Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK.
4​Department of Medicine, University of Cambridge, Cambridge, UK.

Dieter Bulach (D)

5​Melbourne Bioinformatics, The University of Melbourne, Parkville, Australia.
6​Department of Microbiology, Monash University, Clayton, Australia.

Matthew J Belousoff (MJ)

6​Department of Microbiology, Monash University, Clayton, Australia.

Marinjho H Jonduo (MH)

1​Papua New Guinea Institute of Medical Research, Goroka, Papua New Guinea.

Deirdre A Collins (DA)

1​Papua New Guinea Institute of Medical Research, Goroka, Papua New Guinea.
7​School of Medicinal and Health Sciences, Edith Cowan University, Perth, Australia.

Monalisa P Kas (MP)

1​Papua New Guinea Institute of Medical Research, Goroka, Papua New Guinea.

Johanna Wapling (J)

1​Papua New Guinea Institute of Medical Research, Goroka, Papua New Guinea.

Torsten Seemann (T)

5​Melbourne Bioinformatics, The University of Melbourne, Parkville, Australia.

Alice Lafana (A)

1​Papua New Guinea Institute of Medical Research, Goroka, Papua New Guinea.

Gordon Dougan (G)

3​Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK.

Mark V Brown (MV)

8​School of Environmental and Life Sciences, University of Newcastle, Callaghan, NSW, Australia.

Paul F Horwood (PF)

1​Papua New Guinea Institute of Medical Research, Goroka, Papua New Guinea.
9​Australian Institute of Tropical Health and Medicine, James Cook University, Cairns, Australia.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH